Cooper Companies Inc (NYSE:COO) was the recipient of unusually large options trading on Monday. Stock traders purchased 601 call options on the company. This represents an increase of approximately 599% compared to the typical volume of 86 call options.

A number of equities analysts have issued reports on the company. J P Morgan Chase & Co reiterated a “hold” rating and set a $235.00 target price on shares of Cooper Companies in a report on Tuesday, September 12th. Oppenheimer reiterated a “hold” rating and set a $250.00 target price on shares of Cooper Companies in a report on Tuesday, September 12th. Robert W. Baird restated a “buy” rating and set a $273.00 price objective (up from $267.00) on shares of Cooper Companies in a research note on Tuesday, September 12th. Stifel Nicolaus increased their price objective on shares of Cooper Companies from $265.00 to $275.00 and gave the stock a “buy” rating in a research note on Tuesday, September 12th. Finally, Stephens restated an “equal weight” rating and set a $250.00 price objective (up from $235.00) on shares of Cooper Companies in a research note on Tuesday, September 12th. Six investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $259.70.

Institutional investors have recently bought and sold shares of the company. Advisory Services Network LLC lifted its stake in Cooper Companies by 30.6% in the 2nd quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock valued at $109,000 after purchasing an additional 107 shares during the last quarter. Korea Investment CORP lifted its stake in Cooper Companies by 23.9% in the 3rd quarter. Korea Investment CORP now owns 17,109 shares of the medical device company’s stock valued at $4,057,000 after purchasing an additional 3,300 shares during the last quarter. Schwab Charles Investment Management Inc. lifted its stake in Cooper Companies by 5.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 244,686 shares of the medical device company’s stock valued at $58,583,000 after purchasing an additional 13,004 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Cooper Companies by 0.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 185,979 shares of the medical device company’s stock valued at $44,525,000 after purchasing an additional 1,713 shares during the last quarter. Finally, Amalgamated Bank lifted its stake in Cooper Companies by 27.0% in the 2nd quarter. Amalgamated Bank now owns 9,764 shares of the medical device company’s stock valued at $2,338,000 after purchasing an additional 2,073 shares during the last quarter. Institutional investors own 96.79% of the company’s stock.

Cooper Companies (COO) opened at $224.19 on Thursday. Cooper Companies has a one year low of $172.83 and a one year high of $256.39. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.26 and a current ratio of 2.41. The company has a market cap of $11,182.45, a PE ratio of 23.50, a PEG ratio of 1.85 and a beta of 0.54.

Cooper Companies (NYSE:COO) last posted its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, topping the Zacks’ consensus estimate of $2.64 by $0.01. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The company had revenue of $561.50 million during the quarter, compared to the consensus estimate of $558.86 million. During the same period in the prior year, the business posted $2.28 EPS. The company’s quarterly revenue was up 8.3% on a year-over-year basis. research analysts anticipate that Cooper Companies will post 11.51 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://www.watchlistnews.com/cooper-companies-sees-unusually-high-options-volume-coo/1762509.html.

Cooper Companies Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with Analyst Ratings Network's FREE daily email newsletter.